Rylova Svetlana N, Albertioni Freidoun, Flygh Gunnar, Eriksson Staffan
Department of Molecular Biosciences, Section of Veterinary Medical Biochemistry, SLU, The Biomedical Center, P.O. Box 575, Uppsala SE-75123, Sweden.
Biochem Pharmacol. 2005 Mar 15;69(6):951-60. doi: 10.1016/j.bcp.2004.12.010.
Nucleoside reverse transcriptase inhibitor (NRTI) treatment of HIV is associated with complications, including lipodystrophy (LD) and myopathy. Inhibition of mitochondrial DNA polymerase and depletion of mtDNA by NRTI triphosphates are believed to be key mechanisms in NRTI toxicity. Here, we determined the activities and mRNA levels of deoxynucleoside kinases (dNK) and 5'-nucleotidases (5'-NT) controlling the rate-limiting step in intracellular phosphorylation of NRTIs in cell models representing adipose, muscle tissue and peripheral blood cells using specific assays and Taqman RT-PCR. In vitro phosphorylation of 3'-azido-2',3'-dideoxythymidine (AZT) and 2',3'-didehydro-2',3'-dideoxythymidine (d4T) in extracts was also determined. 3T3-L1 adipocytes showed similar activity of mitochondrial thymidine kinase-2 (TK2) and deoxyguanosine kinase (dGK) but 3- to 36-fold lower levels of cytosolic deoxycytidine kinase (dCK), thymidine kinase-1 (TK1) and thymidine monophosphate kinase (TMPK) and higher levels of deoxyribonucleotidase activity compared to proliferating 3T3-L1. dCK, dGK and TK2 activities correlated with their mRNA levels in proliferating, resting and differentiating 3T3-L1. Differentiated L6 myoblasts had lower activities of cytosolic dNK's and TMPK, higher dGK and similar TK2 and deoxyribonucleotidases (dNT) activities compared to proliferating myoblasts. TK2 was the limiting dNK activity while dGK was predominant in adipocytes and myocytes. Activity profiles revealed limited capacity to phosphorylate dThd and dCyd in adipocytes and myocytes compared to proliferating cells and CEM lymphocytes. Phosphorylation of AZT and d4T was low in adipocytes and myocytes, and the presence of these analogs inhibited the phosphorylation of dThd by TK2 suggesting that mitochondrial toxicity of some NRTIs in adipocytes and myocytes is due to the depletion of normal mitochondrial dNTP pools.
核苷类逆转录酶抑制剂(NRTI)治疗HIV与多种并发症相关,包括脂肪代谢障碍(LD)和肌病。NRTI三磷酸酯对线粒体DNA聚合酶的抑制作用以及mtDNA的耗竭被认为是NRTI毒性的关键机制。在此,我们使用特定检测方法和Taqman RT-PCR,在代表脂肪组织、肌肉组织和外周血细胞的细胞模型中,测定了控制NRTI细胞内磷酸化限速步骤的脱氧核苷激酶(dNK)和5'-核苷酸酶(5'-NT)的活性及mRNA水平。还测定了提取物中3'-叠氮-2',3'-双脱氧胸苷(AZT)和2',3'-二脱氢-2',3'-双脱氧胸苷(d4T)的体外磷酸化情况。与增殖的3T3-L1细胞相比,3T3-L1脂肪细胞中线粒体胸苷激酶-2(TK2)和脱氧鸟苷激酶(dGK)活性相似,但胞质脱氧胞苷激酶(dCK)、胸苷激酶-1(TK1)和胸苷单磷酸激酶(TMPK)水平低3至36倍,脱氧核糖核苷酸酶活性更高。在增殖、静止和分化的3T3-L1细胞中,dCK、dGK和TK2活性与其mRNA水平相关。与增殖的成肌细胞相比,分化的L6成肌细胞胞质dNK和TMPK活性较低,dGK活性较高,TK2和脱氧核糖核苷酸酶(dNT)活性相似。TK2是脂肪细胞和成肌细胞中限制性dNK活性,而dGK在脂肪细胞和肌细胞中占主导。活性谱显示,与增殖细胞和CEM淋巴细胞相比,脂肪细胞和成肌细胞中磷酸化dThd和dCyd的能力有限。脂肪细胞和成肌细胞中AZT和d4T的磷酸化水平较低,这些类似物的存在抑制了TK2对dThd的磷酸化,这表明某些NRTI在脂肪细胞和成肌细胞中的线粒体毒性是由于正常线粒体dNTP池的耗竭。